Access to specialized neurological care should never depend on geography or global circumstances. Yet for many international patients, travel disruptions, geopolitical uncertainty, or logistical challenges can suddenly make it difficult to reach the treatments they depend on.
For individuals living with neurological conditions such as Parkinson’s disease, multiple sclerosis, ALS, stroke-related disorders, dementia, and Alzheimer’s disease, timely treatment is essential.
To ensure that patients can continue receiving the care they need, SOZO Brain Center launched the International Patients Initiative, a program designed to bring advanced neuromodulation treatment closer to patients around the world.
This initiative reflects a simple but powerful belief:
Healthcare must remain accessible even when times are uncertain.
Why now?
In recent months, many international patients scheduled to travel to Cyprus for treatment were forced to cancel their trips due to evolving geopolitical conditions and travel restrictions.
For individuals suffering from neurological disorders such as Parkinson’s disease, multiple sclerosis, ALS, dementia, and stroke-related conditions, postponing treatment is not always a viable option. Many neurological conditions require consistent and timely intervention to maintain function, manage symptoms, and improve patient outcomes.
Recognizing the urgency of these circumstances, the team at SOZO Brain Center, led by Chief Neuromodulation Officer Petros Kattou, made a decisive commitment: rather than asking patients to wait, SOZO would bring treatment closer to them.
Through the International Patients Initiative, SOZO Multidisciplinary teams are now traveling to trusted partner clinics worldwide, starting from Berlin, This model allows SOZO to maintain the same medical standards and treatment protocols while expanding access to patients internationally.
If patients cannot travel to SOZO for their treatment, SOZO will travel to the patients.
Why Timely Neuromodulation Treatment Is Critical
Neurological conditions often progress over time. Without timely intervention, symptoms may become more severe and more difficult to manage.
Early and consistent treatment can play a crucial role in:
- supporting neurological recovery
- slowing disease progression
- improving mobility and cognitive function
- enhancing quality of life
When travel disruptions prevent patients from accessing care, these benefits can be delayed.
The International Patients Initiative helps prevent these interruptions by ensuring that patients can continue their neuromodulation treatments without unnecessary delays.
A Growing Global Network of Neuromodulation Care
The International Patients Initiative builds on SOZO’s long-standing commitment to international collaboration in neuromodulation research and treatment.
Through partnerships with physicians and clinics across multiple countries, SOZO has already begun building a global network of professionals trained in its neuromodulation protocols.
This network allows SOZO to deliver treatments internationally while maintaining the same clinical standards and scientific approach used at the SOZO Brain Center.
As this network continues to grow, more patients will gain access to advanced neurological treatments that may not otherwise be available in their region.
Healthcare Should Never Be Limited by Geography
The launch of the International Patients Initiative represents more than a logistical solution to travel challenges.
It reflects a broader vision for the future of medicine — one where advanced treatments are not limited by geography.
Healthcare should be reliable, accessible, and patient-centered, regardless of global circumstances.
By extending its reach through international collaborations and traveling medical teams, SOZO is helping shape a future where specialized neurological care is available to patients wherever they are.
Because when it comes to health, distance should never stand between patients and the treatment they need.
